181 related articles for article (PubMed ID: 33833410)
1. Variants in PRKAR1B cause a neurodevelopmental disorder with autism spectrum disorder, apraxia, and insensitivity to pain.
Marbach F; Stoyanov G; Erger F; Stratakis CA; Settas N; London E; Rosenfeld JA; Torti E; Haldeman-Englert C; Sklirou E; Kessler E; Ceulemans S; Nelson SF; Martinez-Agosto JA; Palmer CGS; Signer RH; ; Andrews MV; Grange DK; Willaert R; Person R; Telegrafi A; Sievers A; Laugsch M; Theiß S; Cheng Y; Lichtarge O; Katsonis P; Stocco A; Schaaf CP
Genet Med; 2021 Aug; 23(8):1465-1473. PubMed ID: 33833410
[TBL] [Abstract][Full Text] [Related]
2. Phenotypic characterization of seven individuals with Marbach-Schaaf neurodevelopmental syndrome.
Marbach F; Lipska-Ziętkiewicz BS; Knurowska A; Michaud V; Margot H; Lespinasse J; Tran Mau Them F; Coubes C; Park J; Grosch S; Roggia C; Grasshoff U; Kalsner L; Denommé-Pichon AS; Afenjar A; Héron B; Keren B; Caro P; Schaaf CP
Am J Med Genet A; 2022 Sep; 188(9):2627-2636. PubMed ID: 35789103
[TBL] [Abstract][Full Text] [Related]
3. BAZ2B haploinsufficiency as a cause of developmental delay, intellectual disability, and autism spectrum disorder.
Scott TM; Guo H; Eichler EE; Rosenfeld JA; Pang K; Liu Z; Lalani S; Bi W; Yang Y; Bacino CA; Streff H; Lewis AM; Koenig MK; Thiffault I; Bellomo A; Everman DB; Jones JR; Stevenson RE; Bernier R; Gilissen C; Pfundt R; Hiatt SM; Cooper GM; Holder JL; Scott DA
Hum Mutat; 2020 May; 41(5):921-925. PubMed ID: 31999386
[TBL] [Abstract][Full Text] [Related]
4. Genomic and sequence variants of protein kinase A regulatory subunit type 1β (PRKAR1B) in patients with adrenocortical disease and Cushing syndrome.
Drougat L; Settas N; Ronchi CL; Bathon K; Calebiro D; Maria AG; Haydar S; Voutetakis A; London E; Faucz FR; Stratakis CA
Genet Med; 2021 Jan; 23(1):174-182. PubMed ID: 32895490
[TBL] [Abstract][Full Text] [Related]
5. ANK3 related neurodevelopmental disorders: expanding the spectrum of heterozygous loss-of-function variants.
Kloth K; Lozic B; Tagoe J; Hoffer MJV; Van der Ven A; Thiele H; Altmüller J; Kubisch C; Au PYB; Denecke J; Bijlsma EK; Lessel D
Neurogenetics; 2021 Oct; 22(4):263-269. PubMed ID: 34218362
[TBL] [Abstract][Full Text] [Related]
6. PRKAR1B mutation associated with a new neurodegenerative disorder with unique pathology.
Wong TH; Chiu WZ; Breedveld GJ; Li KW; Verkerk AJ; Hondius D; Hukema RK; Seelaar H; Frick P; Severijnen LA; Lammers GJ; Lebbink JH; van Duinen SG; Kamphorst W; Rozemuller AJ; ; Bakker EB; ; Neumann M; Willemsen R; Bonifati V; Smit AB; van Swieten J
Brain; 2014 May; 137(Pt 5):1361-73. PubMed ID: 24722252
[TBL] [Abstract][Full Text] [Related]
7. Novel CIC variants identified in individuals with neurodevelopmental phenotypes.
Sharma S; Hourigan B; Patel Z; Rosenfeld JA; Chan KM; Wangler MF; Yi JS; Lehman A; ; Horvath G; Cloos PA; Tan Q
Hum Mutat; 2022 Jul; 43(7):889-899. PubMed ID: 35165976
[TBL] [Abstract][Full Text] [Related]
8. De novo and inherited variants in ZNF292 underlie a neurodevelopmental disorder with features of autism spectrum disorder.
Mirzaa GM; Chong JX; Piton A; Popp B; Foss K; Guo H; Harripaul R; Xia K; Scheck J; Aldinger KA; Sajan SA; Tang S; Bonneau D; Beck A; White J; Mahida S; Harris J; Smith-Hicks C; Hoyer J; Zweier C; Reis A; Thiel CT; Jamra RA; Zeid N; Yang A; Farach LS; Walsh L; Payne K; Rohena L; Velinov M; Ziegler A; Schaefer E; Gatinois V; Geneviève D; Simon MEH; Kohler J; Rotenberg J; Wheeler P; Larson A; Ernst ME; Akman CI; Westman R; Blanchet P; Schillaci LA; Vincent-Delorme C; Gripp KW; Mattioli F; Guyader GL; Gerard B; Mathieu-Dramard M; Morin G; Sasanfar R; Ayub M; Vasli N; Yang S; Person R; Monaghan KG; Nickerson DA; van Binsbergen E; Enns GM; Dries AM; Rowe LJ; Tsai ACH; Svihovec S; Friedman J; Agha Z; Qamar R; Rodan LH; Martinez-Agosto J; Ockeloen CW; Vincent M; Sunderland WJ; Bernstein JA; ; Eichler EE; Vincent JB; ; Bamshad MJ
Genet Med; 2020 Mar; 22(3):538-546. PubMed ID: 31723249
[TBL] [Abstract][Full Text] [Related]
9. Refining the role of de novo protein-truncating variants in neurodevelopmental disorders by using population reference samples.
Kosmicki JA; Samocha KE; Howrigan DP; Sanders SJ; Slowikowski K; Lek M; Karczewski KJ; Cutler DJ; Devlin B; Roeder K; Buxbaum JD; Neale BM; MacArthur DG; Wall DP; Robinson EB; Daly MJ
Nat Genet; 2017 Apr; 49(4):504-510. PubMed ID: 28191890
[TBL] [Abstract][Full Text] [Related]
10. De novo variants in AGO1 recapitulate a heterogeneous neurodevelopmental disorder phenotype.
Niu Y; Qian Q; Li J; Gong P; Jiao X; Mao X; Xiao B; Long L; Yang Z
Clin Genet; 2022 Apr; 101(4):459-465. PubMed ID: 35060114
[TBL] [Abstract][Full Text] [Related]
11. De novo MCM6 variants in neurodevelopmental disorders: a recognizable phenotype related to zinc binding residues.
Smits DJ; Schot R; Popescu CA; Dias KR; Ades L; Briere LC; Sweetser DA; Kushima I; Aleksic B; Khan S; Karageorgou V; Ordonez N; Sleutels FJGT; van der Kaay DCM; Van Mol C; Van Esch H; Bertoli-Avella AM; Roscioli T; Mancini GMS
Hum Genet; 2023 Jul; 142(7):949-964. PubMed ID: 37198333
[TBL] [Abstract][Full Text] [Related]
12. Monoallelic
Ravindran E; Arashiki N; Becker LL; Takizawa K; Lévy J; Rambaud T; Makridis KL; Goshima Y; Li N; Vreeburg M; Demeer B; Dickmanns A; Stegmann APA; Hu H; Nakamura F; Kaindl AM
Elife; 2022 Dec; 11():. PubMed ID: 36511780
[TBL] [Abstract][Full Text] [Related]
13. Variants in GNAI1 cause a syndrome associated with variable features including developmental delay, seizures, and hypotonia.
Muir AM; Gardner JF; van Jaarsveld RH; de Lange IM; van der Smagt JJ; Wilson GN; Dubbs H; Goldberg EM; Zitano L; Bupp C; Martinez J; Srour M; Accogli A; Alhakeem A; Meltzer M; Gropman A; Brewer C; Caswell RC; Montgomery T; McKenna C; McKee S; Powell C; Vasudevan PC; Brady AF; Joss S; Tysoe C; Noh G; Tarnopolsky M; Brady L; Zafar M; Schrier Vergano SA; Murray B; Sawyer L; Hainline BE; Sapp K; DeMarzo D; Huismann DJ; Wentzensen IM; Schnur RE; Monaghan KG; Juusola J; Rhodes L; Dobyns WB; Lecoquierre F; Goldenberg A; Polster T; Axer-Schaefer S; Platzer K; Klöckner C; Hoffman TL; MacArthur DG; O'Leary MC; VanNoy GE; England E; Varghese VC; Mefford HC
Genet Med; 2021 May; 23(5):881-887. PubMed ID: 33473207
[TBL] [Abstract][Full Text] [Related]
14. Deleterious Variation in BRSK2 Associates with a Neurodevelopmental Disorder.
Hiatt SM; Thompson ML; Prokop JW; Lawlor JMJ; Gray DE; Bebin EM; Rinne T; Kempers M; Pfundt R; van Bon BW; Mignot C; Nava C; Depienne C; Kalsner L; Rauch A; Joset P; Bachmann-Gagescu R; Wentzensen IM; McWalter K; Cooper GM
Am J Hum Genet; 2019 Apr; 104(4):701-708. PubMed ID: 30879638
[TBL] [Abstract][Full Text] [Related]
15. The clinical and molecular spectrum of QRICH1 associated neurodevelopmental disorder.
Kumble S; Levy AM; Punetha J; Gao H; Ah Mew N; Anyane-Yeboa K; Benke PJ; Berger SM; Bjerglund L; Campos-Xavier B; Ciliberto M; Cohen JS; Comi AM; Curry C; Damaj L; Denommé-Pichon AS; Emrick L; Faivre L; Fasano MB; Fiévet A; Finkel RS; García-Miñaúr S; Gerard A; Gomez-Puertas P; Guillen Sacoto MJ; Hoffman TL; Howard L; Iglesias AD; Izumi K; Larson A; Leiber A; Lozano R; Marcos-Alcalde I; Mintz CS; Mullegama SV; Møller RS; Odent S; Oppermann H; Ostergaard E; Pacio-Míguez M; Palomares-Bralo M; Parikh S; Paulson AM; Platzer K; Posey JE; Potocki L; Revah-Politi A; Rio M; Ritter AL; Robinson S; Rosenfeld JA; Santos-Simarro F; Sousa SB; ; Wéber M; Xie Y; Chung WK; Brown NJ; Tümer Z
Hum Mutat; 2022 Feb; 43(2):266-282. PubMed ID: 34859529
[TBL] [Abstract][Full Text] [Related]
16. Truncating Variants in NAA15 Are Associated with Variable Levels of Intellectual Disability, Autism Spectrum Disorder, and Congenital Anomalies.
Cheng H; Dharmadhikari AV; Varland S; Ma N; Domingo D; Kleyner R; Rope AF; Yoon M; Stray-Pedersen A; Posey JE; Crews SR; Eldomery MK; Akdemir ZC; Lewis AM; Sutton VR; Rosenfeld JA; Conboy E; Agre K; Xia F; Walkiewicz M; Longoni M; High FA; van Slegtenhorst MA; Mancini GMS; Finnila CR; van Haeringen A; den Hollander N; Ruivenkamp C; Naidu S; Mahida S; Palmer EE; Murray L; Lim D; Jayakar P; Parker MJ; Giusto S; Stracuzzi E; Romano C; Beighley JS; Bernier RA; Küry S; Nizon M; Corbett MA; Shaw M; Gardner A; Barnett C; Armstrong R; Kassahn KS; Van Dijck A; Vandeweyer G; Kleefstra T; Schieving J; Jongmans MJ; de Vries BBA; Pfundt R; Kerr B; Rojas SK; Boycott KM; Person R; Willaert R; Eichler EE; Kooy RF; Yang Y; Wu JC; Lupski JR; Arnesen T; Cooper GM; Chung WK; Gecz J; Stessman HAF; Meng L; Lyon GJ
Am J Hum Genet; 2018 May; 102(5):985-994. PubMed ID: 29656860
[TBL] [Abstract][Full Text] [Related]
17. Pathogenic variants in USP7 cause a neurodevelopmental disorder with speech delays, altered behavior, and neurologic anomalies.
Fountain MD; Oleson DS; Rech ME; Segebrecht L; Hunter JV; McCarthy JM; Lupo PJ; Holtgrewe M; Moran R; Rosenfeld JA; Isidor B; Le Caignec C; Saenz MS; Pedersen RC; Morgan TM; Pfotenhauer JP; Xia F; Bi W; Kang SL; Patel A; Krantz ID; Raible SE; Smith W; Cristian I; Torti E; Juusola J; Millan F; Wentzensen IM; Person RE; Küry S; Bézieau S; Uguen K; Férec C; Munnich A; van Haelst M; Lichtenbelt KD; van Gassen K; Hagelstrom T; Chawla A; Perry DL; Taft RJ; Jones M; Masser-Frye D; Dyment D; Venkateswaran S; Li C; Escobar LF; Horn D; Spillmann RC; Peña L; Wierzba J; Strom TM; Parenti I; Kaiser FJ; Ehmke N; Schaaf CP
Genet Med; 2019 Aug; 21(8):1797-1807. PubMed ID: 30679821
[TBL] [Abstract][Full Text] [Related]
18. Heterozygous variants in CTR9, which encodes a major component of the PAF1 complex, are associated with a neurodevelopmental disorder.
Meuwissen M; Verstraeten A; Ranza E; Iwaszkiewicz J; Bastiaansen M; Mateiu L; Nemegeer M; Meester JAN; Afenjar A; Amaral M; Ballhausen D; Barnett S; Barth M; Asselbergh B; Spaas K; Heeman B; Bassetti J; Blackburn P; Schaer M; Blanc X; Zoete V; Casas K; Courtin T; Doummar D; Guerry F; Keren B; Pappas J; Rabin R; Begtrup A; Shinawi M; Vulto-van Silfhout AT; Kleefstra T; Wagner M; Ziegler A; Schaefer E; Gerard B; De Bie CI; Holwerda SJB; Abbot MA; Antonarakis SE; Loeys B
Genet Med; 2022 Jul; 24(7):1583-1591. PubMed ID: 35499524
[TBL] [Abstract][Full Text] [Related]
19. De novo missense variants in the E3 ubiquitin ligase adaptor KLHL20 cause a developmental disorder with intellectual disability, epilepsy, and autism spectrum disorder.
Sleyp Y; Valenzuela I; Accogli A; Ballon K; Ben-Zeev B; Berkovic SF; Broly M; Callaerts P; Caylor RC; Charles P; Chatron N; Cohen L; Coppola A; Cordeiro D; Cuccurullo C; Cuscó I; Janette diMonda ; Duran-Romaña R; Ekhilevitch N; Fernández-Alvarez P; Gordon CT; Isidor B; Keren B; Lesca G; Maljaars J; Mercimek-Andrews S; Morrow MM; Muir AM; ; Rousseau F; Salpietro V; Scheffer IE; Schnur RE; Schymkowitz J; Souche E; Steyaert J; Stolerman ES; Vengoechea J; Ville D; Washington C; Weiss K; Zaid R; Sadleir LG; Mefford HC; Peeters H
Genet Med; 2022 Dec; 24(12):2464-2474. PubMed ID: 36214804
[TBL] [Abstract][Full Text] [Related]
20. Variant-specific effects define the phenotypic spectrum of HNRNPH2-associated neurodevelopmental disorders in males.
Kreienkamp HJ; Wagner M; Weigand H; McConkie-Rossell A; McDonald M; Keren B; Mignot C; Gauthier J; Soucy JF; Michaud JL; Dumas M; Smith R; Löbel U; Hempel M; Kubisch C; Denecke J; Campeau PM; Bain JM; Lessel D
Hum Genet; 2022 Feb; 141(2):257-272. PubMed ID: 34907471
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
